I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Saunders, Mark P.
3207
results:
Articles (Online) X
Search for persons
X
Languages
english (3056)
german (2)
more...
french (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Durable responses to ATR inhibition with ceralasertib in tu..:
Dillon, Magnus T.
;
Guevara, Jeane
;
Mohammed, Kabir
...
Journal of Clinical Investigation. 134 (2024) 2 - p. , 2024
Link:
https://doi.org/10.1172/..
?
2
Multiplex analysis of intratumoural immune infiltrate and p..:
Frei, Anja L
;
McGuigan, Anthony
;
Sinha, Ritik R A K
...
The Lancet Oncology. 25 (2024) 2 - p. 198-211 , 2024
Link:
https://doi.org/10.1016/..
?
3
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemoth..:
Saunders, Mark P.
;
Iype, Rohan
;
Kelly, Caroline
...
Clinical Colorectal Cancer. 22 (2023) 2 - p. 231-237 , 2023
Link:
https://doi.org/10.1016/..
?
4
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signal..:
Propper, David J.
;
Gao, Fangfei
;
Saunders, Mark P.
...
British Journal of Cancer. 128 (2022) 2 - p. 245-254 , 2022
Link:
https://doi.org/10.1038/..
?
5
ASO Visual Abstract: RAS Mutation Status Should not be Used..:
Bhullar, Dilraj
;
O'Dwyer, Sarah
;
Wilson, Malcolm
...
Annals of Surgical Oncology. 30 (2022) 2 - p. 802-803 , 2022
Link:
https://doi.org/10.1245/..
?
6
RAS Mutation Status Should Not Be Used to Predict Outcome f..:
Bhullar, Dilraj
;
O'Dwyer, Sarah
;
Wilson, Malcolm
...
Annals of Surgical Oncology. 30 (2022) 2 - p. 792-801 , 2022
Link:
https://doi.org/10.1245/..
?
7
Clinical and radiomics prediction of complete response in r..:
Mbanu, Peter
;
Saunders, Mark P.
;
Mistry, Hitesh
...
Physics and Imaging in Radiation Oncology. 23 (2022) - p. 48-53 , 2022
Link:
https://doi.org/10.1016/..
?
8
Three-dimensional (3D) magnetic resonance volume assessment..:
Sekhar, Hema
;
Kochhar, Rohit
;
Carrington, Bernadette
...
BMC Cancer. 20 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
9
Blood-basedRASmutation testing: concordance with tissue-bas..:
Germetaki, Theodora
;
Nicholls, Camille
;
Adams, Richard A
...
Future Oncology. 16 (2020) 28 - p. 2177-2189 , 2020
Link:
https://doi.org/10.2217/..
?
10
Temporal improvements in loco-regional failure and survival..:
Sekhar, Hema
;
Malcomson, Lee
;
Kochhar, Rohit
...
British Journal of Cancer. 122 (2020) 6 - p. 749-758 , 2020
Link:
https://doi.org/10.1038/..
?
11
Pattern Recognition Receptor Polymorphisms as Predictors of..:
Gray, Victoria
;
Briggs, Sarah
;
Palles, Claire
...
JNCI: Journal of the National Cancer Institute. 111 (2019) 8 - p. 828-836 , 2019
Link:
https://doi.org/10.1093/..
?
12
Management and Grading of EGFR Inhibitor-Induced Cutaneous ..:
Beech, Janette
;
Germetaki, Theodora
;
Judge, Mary
...
Future Oncology. 14 (2018) 24 - p. 2531-2541 , 2018
Link:
https://doi.org/10.2217/..
?
13
A core outcome set for clinical trials of chemoradiotherapy..:
Fish, Rebecca
;
Sanders, Caroline
;
Adams, Richard
...
The Lancet Gastroenterology & Hepatology. 3 (2018) 12 - p. 865-873 , 2018
Link:
https://doi.org/10.1016/..
?
14
SCOT: a comparison of cost-effectiveness from a large rando..:
Robles-Zurita, José
;
Boyd, Kathleen A.
;
Briggs, Andrew H.
...
British Journal of Cancer. 119 (2018) 11 - p. 1332-1338 , 2018
Link:
https://doi.org/10.1038/..
?
15
Plasma Tie2 is a tumor vascular response biomarker for VEGF..:
Jayson, Gordon C.
;
Zhou, Cong
;
Backen, Alison
...
Nature Communications. 9 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1038/..
1-15